http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
The Supreme Cannabis Company, Inc. Mails Information Circular for Special Meeting of Shareholders
-
Supreme Cannabis Announces Financial Results for Q3 2021
-
Clarify Pharma PLC Intention to Float on AQSE Growth Market
-
Supreme Cannabis Schedules Third Quarter 2021 Financial Results Release and Conference Call
-
Canopy Growth (CGC) to Acquire The Supreme Cannabis Company (SPRWF) for ~$435M in Mostly Stock
-
Canopy Growth to Acquire The Supreme Cannabis Company
-
Supreme Cannabis Launches Sugarleaf THC Gummies
-
Supreme Cannabis Announces Financial Results for Q2 2021
-
Supreme Cannabis Schedules Second Quarter 2021 Financial Results Release and Conference Call
-
Supreme Cannabis Expands International Medical Cannabis Shipments
-
Supreme Cannabis Announces Financial Results for Q1 2021
-
Supreme Cannabis Enters into Supply Agreements with Medical Cannabis by Shoppers
-
Supreme Cannabis Announces Voting Results of the 2020 Annual General Meeting of Shareholders
-
Supreme Cannabis Schedules First Quarter 2021 Financial Results Release and Conference Call
-
Supreme Cannabis Announces Financial Results for Q4 and Full-year 2020
-
Supreme Cannabis Amends Credit Facility
-
Supreme Cannabis Effects Debenture Amendments
-
Supreme Cannabis Schedules Fourth Quarter and Year-end 2020 Financial Results Release and Conference Call
-
Supreme Cannabis Files Prospectus Supplement
-
Supreme Cannabis Obtains Approval from Debentureholders to Partially Convert and Amend Debentures
-
Supreme Cannabis and KKE Canada Announce Mutual Termination of International Partnership
-
Supreme Cannabis Launches New Affordable Cannabis Brand Hiway
-
Sugarleaf Launches New Convenience Products for the Modern Cannabis Consumer
-
Supreme Cannabis Announces Change to its Board of Directors
-
Supreme Cannabis Announces Q3 2020 Financial Results
-
7ACRES Helps Consumers Discover their Cannabis Taste Buds
-
Supreme Cannabis Third Quarter Earnings Release Scheduled for May 15, 2020
-
7ACRES Launches New Craft Brand Extension, Craft Collective
-
Supreme Cannabis Appoints Beena Goldenberg as President and CEO
-
Supreme Cannabis Completes First Shipment to Israel and Provides Corporate Update
-
humble+fume Announces Sales Agency Agreement with Supreme Cannabis
-
Supreme Cannabis Announces Q2 2020 Financial Results and Updated Plan for Accelerated Revenue Growth
-
Supreme Cannabis Focuses Organization and Reduces Cost Structure to Accelerate Profitable Growth
-
Supreme Cannabis Second Quarter Earnings Release Scheduled for February 13, 2020
-
Supreme Cannabis Announces Leadership Transition as Company Accelerates Transformation into Premium Cannabis CPG Company
-
Supreme Cannabis Expands 7ACRES to New Markets
-
Supreme Cannabis Announces Intention to Appoint Global Marketing Executive Jackie Poriadjian-Asch to its Board
-
Supreme Cannabis Expands CPG Manufacturing Capacity and Provides Operational Update
-
Supreme Cannabis Welcomes New General Manager to 7ACRES
-
Supreme Cannabis Welcomes Global CPG Executive John Griese as Chief Operating Officer
-
Supreme Cannabis' Wellness Focused Brand, Blissco, Launches New CBD Oil, Pūr Dew
-
Supreme Cannabis Announces Q1 2020 Financial Results and $90 million Credit Facility led by Bank of Montreal
-
Supreme Cannabis First Quarter Earnings Release Scheduled for November 14, 2019
-
Supreme Cannabis Strengthens Sales Strategy with New Senior Vice President of Commercial
-
Supreme Cannabis' Wellness Brand, Blissco, Receives Cannabis Oil Sales License
-
Supreme Cannabis Announces Q4 and 2019 Fiscal Year End Financial Results
-
Supreme Cannabis' High End Brand, 7ACRES, Launches New Cultivar: Jack Haze
-
Supreme Cannabis Provides Guidance for Positive Fourth Quarter 2019 and Fiscal 2020
-
Supreme Cannabis Appoints New Chief Information Officer and VP of Talent
-
Supreme Cannabis to acquire Truverra as it prepares for Legalization 2.0 and Global Medical Markets

